Polish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Cureus 2017-Jan

Ocular Inflammatory Disease as a Predictor for In-Hospital Mortality in Patients Hospitalized with Disseminated Tuberculosis.

Tylko zarejestrowani użytkownicy mogą tłumaczyć artykuły
Zaloguj się Zarejestruj się
Link zostanie zapisany w schowku
Salil Mehta

Słowa kluczowe

Abstrakcyjny

OBJECTIVE

To ascertain whether the presence of ocular inflammatory disease is a predictor for death in patients hospitalized with disseminated tuberculosis.

METHODS

This is an IRB-approved retrospective study of patients admitted with a diagnosis of disseminated tuberculosis within a seven-year period (2002-2009). The following data was collected from each record: age, sex, details of previous surgeries or therapy, the findings of anterior segment examination, the findings of dilated indirect ophthalmoscopy, systemic findings, investigations done, treatment rendered, and final status (died or discharged).

RESULTS

A total of 57 patients (29 males (50.8%), 28 females (49.2%) with ages ranging from 14 to 78 years (mean 41.7 years) were identified. Common presentations included fever, sepsis or neurological complaints such as headache or convulsions. Significant medical histories included acquired immune deficiency syndrome (AIDS) (n= 4), renal allograft transplantation (n=3), chronic renal failure on hemodialysis (n=3) and type 2 diabetes mellitus (n=6). Of these, 35 patients (61.4%) had ocular tuberculosis. These included 19 males (54.2%) and 16 females (46.8%) with ages ranging from 16 to 78 years (mean 43.3 years). Current medical conditions included AIDS, renal allograft transplantation and subsequent immunosuppressive therapy, chronic renal failure on hemodialysis, and type 2 diabetes mellitus. Forty-seven of the 70 eyes (67.1%) had evidence of ocular tuberculosis. Specific presentations included 42 eyes (89.1%) with choroidal tubercles and five eyes (10.9%) with chorioretinitis. Two patients (2.8%) had disc edema. Of these 35 patients, eight (22.8%) patients died whereas 27 (77.2%) were discharged. The remaining 22 patients (38.6%) had no ocular tuberculosis. These included 10 males (45.5%) and 12 females (54.5%) with ages ranging from 14 to 78 years (mean 39.1 years). Significant medical histories included type 2 diabetes mellitus. Of these 44 eyes, four eyes (9.09%) had non-proliferative diabetic retinopathy, two eyes (4.5%) had optic atrophy and two eyes (4.5%) had disc edema. One patient (4.5%) patient of this group of 22 died, whereas 21 (95.5%) were discharged. We analyzed the differences in survival with Fisher's Exact test between patients who died in the hospital and those who were discharged (statistically insignificant at p value of 0.05). Outcomes of patients with two, three, or four risk factors were analyzed using unconditional logistic regression but all tests failed to reach statistical significance.

CONCLUSIONS

The presence of ocular inflammation was independent of final outcome, either singly or as part of a risk factor cluster.

Dołącz do naszej strony
na Facebooku

Najbardziej kompletna baza danych ziół leczniczych poparta naukowo

  • Działa w 55 językach
  • Ziołowe leki poparte nauką
  • Rozpoznawanie ziół na podstawie obrazu
  • Interaktywna mapa GPS - oznacz zioła na miejscu (wkrótce)
  • Przeczytaj publikacje naukowe związane z Twoim wyszukiwaniem
  • Szukaj ziół leczniczych po ich działaniu
  • Uporządkuj swoje zainteresowania i bądź na bieżąco z nowościami, badaniami klinicznymi i patentami

Wpisz objaw lub chorobę i przeczytaj o ziołach, które mogą pomóc, wpisz zioło i zobacz choroby i objawy, na które są stosowane.
* Wszystkie informacje oparte są na opublikowanych badaniach naukowych

Google Play badgeApp Store badge